Saturday, November 16, 2024
HomeTagsChaim Lebovits

Chaim Lebovits

BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced that the U.S. Food and Drug Administration (FDA)...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics